•             

Cart 0

Epithelial-to-Mesenchymal Transition Markers

The Epithelial to epithelial-to-mesenchymal transition (EMT) antibody marker panel comprises a comprehensive array of mouse monoclonals meticulously designed to target critical EMT markers associated with various cellular processes. This collection offers targeted insights into key facets of EMT, encompassing alterations in cell junctions, cytoskeletal dynamics, transcriptional regulation, and cellular migration and motility.

Within the EMT process, specific protein markers play pivotal roles in delineating the transition from an epithelial to a mesenchymal phenotype, indicative of changes in cell behavior and function.

Some noteworthy protein markers specific to the EMT include:

  • E-Cadherin: E-Cadherin is a classic epithelial marker whose downregulation is a hallmark of EMT. Reduction in E-Cadherin levels contributes to the loss of cell adhesion characteristic of mesenchymal cells.
  • N-Cadherin: N-Cadherin, a mesenchymal marker, is often upregulated during EMT. The switch from E-Cadherin to N-Cadherin expression is associated with increased cell motility and invasion.
  • Vimentin: Vimentin is a cytoskeletal protein whose increased expression is indicative of mesenchymal transformation. It plays a role in maintaining cell structure and promoting motility.
  • Snail, Slug, and Twist: These transcription factors are key regulators of EMT, orchestrating the repression of epithelial markers and induction of mesenchymal markers. Their overexpression is associated with enhanced migratory and invasive properties.
  • Fibronectin: Fibronectin is an extracellular matrix protein whose upregulation is linked to the mesenchymal phenotype. It influences cell adhesion and migration during EMT.
The Epithelial to Mesenchymal Transition antibody marker panel provides a valuable tool for researchers to explore and characterize these critical EMT markers, advancing our understanding of cellular plasticity and contributing to the development of targeted therapeutic strategies in various disease contexts, including cancer metastasis and tissue regeneration.


DOWNLOAD WHITE PAPER
Anti-MMP9 Antibody
Anti-MMP9 Antibody

Anti-MMP9 Antibody

AMAb90804
In Stock (10+)
3 665,0 kr
Anti-MMP9 Antibody
Anti-MMP9 Antibody

Anti-MMP9 Antibody

AMAb90805
In Stock (10+)
3 665,0 kr
Anti-MMP9 Antibody
Anti-MMP9 Antibody

Anti-MMP9 Antibody

AMAb90806
In Stock (10+)
3 665,0 kr
Anti-CTNNB1 Antibody
Anti-CTNNB1 Antibody

Anti-CTNNB1 Antibody

AMAb91209
In Stock (10+)
3 665,0 kr
Anti-CTNNB1 Antibody
Anti-CTNNB1 Antibody

Anti-CTNNB1 Antibody

AMAb91210
In Stock (10+)
3 665,0 kr
Anti-ZEB1 Antibody
Anti-ZEB1 Antibody

Anti-ZEB1 Antibody

AMAb90510
In Stock (10+)
4 311,0 kr
Anti-SIX1 Antibody
Anti-SIX1 Antibody

Anti-SIX1 Antibody

AMAb90544
In Stock (10+)
4 311,0 kr
Anti-S100A4 Antibody
Anti-S100A4 Antibody

Anti-S100A4 Antibody

AMAb90596
In Stock (10+)
4 311,0 kr
Anti-CDH1 Antibody
Anti-CDH1 Antibody

Anti-CDH1 Antibody

AMAb90865
In Stock (10+)
3 665,0 kr
Anti-OCLN Antibody
Anti-OCLN Antibody

Anti-OCLN Antibody

AMAb90889
In Stock (10+)
4 311,0 kr
Anti-OCLN Antibody
Anti-OCLN Antibody

Anti-OCLN Antibody

AMAb90890
In Stock (10+)
4 311,0 kr
Anti-OCLN Antibody
Anti-OCLN Antibody

Anti-OCLN Antibody

AMAb90893
In Stock (10+)
4 311,0 kr
Anti-TP63 Antibody
Anti-TP63 Antibody

Anti-TP63 Antibody

AMAb91224
In Stock (10+)
3 665,0 kr